SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-139072
Filing Date
2018-04-27
Accepted
2018-04-27 16:34:03
Documents
5
Period of Report
2018-06-21
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d546319ddef14a.htm DEF 14A 280972
2 GRAPHIC g546319g38i82.jpg GRAPHIC 22361
3 GRAPHIC g546319g99w55.jpg GRAPHIC 35491
4 GRAPHIC g546319snap1.jpg GRAPHIC 200975
5 GRAPHIC g546319snap2.jpg GRAPHIC 113960
  Complete submission text file 0001193125-18-139072.txt   796021
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36003 | Film No.: 18784537
SIC: 2834 Pharmaceutical Preparations